An Open-Label Exploratory Study with Memantine: Correlation between Proton Magnetic Resonance Spectroscopy and Cognition in Patients with Mild to Moderate Alzheimer's Disease

被引：0
|
作者：
Gordon, Marc [1 ]
Kingsley, Peter [2 ]
Goldberg, Terry
Koppel, Jeremy
Christen, Erica
Keehlisen, Lynda
Kohn, Nina [3 ]
Davies, Peter
机构：
[1] N Shore LIJ Hlth Syst, Litwin Zucker Res Ctr, Neurol & Psychiat, Manhasset, NY USA
[2] N Shore LIJ Hlth Syst, Radiol, Manhasset, NY USA
[3] N Shore LIJ Hlth Syst, Biostat, Manhasset, NY USA
来源：
NEUROLOGY | 2012年 / 78卷
关键词：
D O I：
暂无
中图分类号：
R74 [神经病学与精神病学];
学科分类号：
摘要：
P04198
引用
收藏
页数：3
相关论文
共 50 条
  • [41] Proton magnetic resonance spectroscopy and white matter hyperintensities on magnetic resonance imaging in patients with Alzheimer's disease
    Watanabe, T
    Akiguchi, I
    Yagi, H
    Onishi, K
    Kawasaki, T
    Shiino, A
    Inubushi, T
    ALZHEIMER'S DISEASE: VASCULAR ETIOLOGY AND PATHOLOGY, 2002, 977 : 423 - 429
  • [42] Long-term treatment with the NMDA antagonist, memantine:: Results of a 24-week, open-label extension study in moderate to severe Alzheimer's disease
    Ferris, SH
    Schmitt, FA
    Doody, R
    Möbius, HJ
    Stöffler, A
    Reisberg, B
    INTERNATIONAL PSYCHOGERIATRICS, 2003, 15 : 258 - 259
  • [43] Combination treatment with galantamine and memantine: Safety data in patients with mild to moderate Alzheimer's disease
    Crivera, C.
    Amatniek, J.
    Zhu, Y.
    Rupnow, M.
    Parsons, L.
    Cimms, T.
    Verhoff, R.
    Donnelly, S.
    Van Oene, J. C.
    EUROPEAN JOURNAL OF NEUROLOGY, 2007, 14 : 59 - 59
  • [44] Effects on agitation with rivastigmine patch monotherapy and combination therapy with memantine in mild to moderate Alzheimer's disease: a multicenter 24-week prospective randomized open-label study (the Korean EXelon Patch and combination with mEmantine Comparative Trial study)
    Yoon, Soo J.
    Choi, Seong H.
    Na, Hae R.
    Park, Kyung-Won
    Kim, Eun-Joo
    Han, Hyun J.
    Lee, Jae-Hong
    Shim, Young S.
    Na, Duk L.
    GERIATRICS & GERONTOLOGY INTERNATIONAL, 2017, 17 (03) : 494 - 499
  • [45] Safety and efficacy of donepezil in a 12-week, open-label trial in African Americans with mild to moderate Alzheimer's disease
    Griffith, P
    Lichtenberg, P
    Goldman, R
    Payne-Parrish, J
    Richardson, S
    NEUROLOGY, 2005, 64 (06) : A366 - A366
  • [46] Donepezil Combined with Natural Hirudin Improves the Clinical Symptoms of Patients with Mild-to-Moderate Alzheimer's Disease: A 20-Week Open-Label Pilot Study
    Li, De-qiang
    Zhou, Yu-ping
    Yang, Han
    INTERNATIONAL JOURNAL OF MEDICAL SCIENCES, 2012, 9 (03): : 248 - 255
  • [47] The study of hydrogen proton magnetic resonance spectroscopy of the hippocampus of patients with dementia with Lewy bodies and Alzheimer's disease
    钟笑梅
    China Medical Abstracts (Internal Medicine), 2013, (01) : 62 - 62
  • [48] Long-term treatment with the NMDA antagonist, memantine: Results of a 24-week, open-label extension study in moderate to severe Alzheimer's disease.
    Ferris, SH
    Schmitt, FA
    Doody, RS
    Moebius, H
    Stoeffler, A
    Reisberg, BJ
    JOURNAL OF THE AMERICAN GERIATRICS SOCIETY, 2003, 51 (04) : S77 - S78
  • [49] Changes in Nursing Burden Following Memantine for Agitation and Aggression in Long-Term Care Residents with Moderate to Severe Alzheimer's Disease An Open-Label Pilot Study
    Herrmann, Nathan
    Cappell, Jaclyn
    Eryavec, Goran M.
    Lanctot, Krista L.
    CNS DRUGS, 2011, 25 (05) : 425 - 433
  • [50] Safety and efficacy of donepezil in African Americans with mild to moderate Alzheimer's disease: A 12-week open-label trial.
    Griffith, P
    Lichtenberg, P
    Goldman, R
    Payne-Parrish, J
    Richardson, S
    JOURNAL OF THE AMERICAN GERIATRICS SOCIETY, 2005, 53 (04) : S76 - S76
12345